Arrow Electronics, Inc. (NYSE: ARW) — The Value Stock That Forgot It Was Cyclical

Report date: 2026-07-24. All figures reconciled to SEC filings; third-party data labeled. This article takes no position and contains no price target — the single, deliberate exception is the labeled Claude's Take block immediately below, which is the author’s own independent view.

⚡ Claude’s Take

This is the author’s own subjective opinion and general information, not investment advice. The analysis that follows (Sections 1–15) takes no position and carries no price target.

Verdict: HOLD / AVOID-here — a genuinely good #1/#2 distribution franchise bought at the wrong point in the cycle at the richest multiple in its history. Conviction: medium. At ~$215 Arrow trades at ~15x trailing GAAP earnings, ~1.7x book, ~2.5x tangible book, and ~0.44x EV/Sales — the ~91st percentile of its own ten-year valuation range, and literally its richest-ever reading on price-to-sales (99th percentile). That is a remarkable place for a business that, by management’s own compensation disclosure, generated a three-year average ROIC of just 1.11% above its cost of capital. I would happily own Arrow — but in the high-$120s to mid-$150s (roughly 8–10x normalized EPS and at/near book value, where it spent most of the last five years and where the interim CEO himself bought stock in February at $151.87), not at a doubled price that already capitalizes a sustained upcycle. The bull’s “only ~11x forward earnings” is the oldest trap in cyclical investing: 11x on 2026’s recovery/near-peak EPS is ~15x trailing and ~13–15x on mid-cycle earnings — a full multiple for an 8%-ROIC, sub-4%-operating-margin commodity distributor.

The framing is unambiguous, and the tape proves it. Arrow’s single closest statistical cousin in factor space is the iShares USA Value Factor ETF (VLUE, 0.94 similarity), with Avnet right behind it — its factor identity is deep-value cyclical. Yet the last six months have been pure momentum: ~+82% actual price gain, a 6-month Sharpe of 5.6, while its ten-year annualized return is ~13% against a −73% lifetime drawdown. A formerly-abandoned value name that has become a crowded momentum trade — screening simultaneously as a Zacks “Strong Buy value” and a “top momentum” stock, which is the crowding tell, not a confirmation. The AI/data-center tailwind is real (ECS billings +39%, hyperscaler supply-chain-services pull-forward), but it is being financed by a receivables balloon (AR +51% to $19.7B, DSO ~234 days) and it rides a components restocking cycle that always mean-reverts. Flip me bullish if book-to-bill holds above 1 across all three regions into 2027 and value-added services durably lift through-cycle operating margin toward 5%+ (a structural re-rate, not a cycle bounce). Flip me bearish if book-to-bill rolls back below parity or the SCS-driven receivables reverse hard and expose a working-capital air-pocket — the signature way distributors disappoint after a restock. Tag: “The value stock that forgot it was cyclical.”

📈 Stock Price Action — Five-Year Event Map

Over five years Arrow round-tripped a shortage-era boom and a destocking bust inside a $90–$142 band, then broke decisively to all-time highs in 2026. From an April 2025 low of ~$90 the stock has more than doubled; it trades near ~$215 today against a 52-week range of ~$102–$237, roughly 9% below its high. The move that matters is entirely a 2026 event: a formerly range-bound value cyclical re-rated ~100% year-to-date on an AI/data-center-plus-components-restocking narrative.

Cycle narrative. (1–2) The 2021–22 chip shortage drove record revenue and a $22 diluted EPS, but the stock peaked mid-2022 and fell ~30% as rates spiked and orders rolled over — the market read the cycle before the P&L did. (3) A 2023 bounce to ~$147 rode residual backlog and a heavy buyback, but (4) H2 2023–April 2025 was a textbook destocking recession: revenue fell to a $27.9B trough and the stock retraced to ~$90. (5) The turn is dateable to the Q4’25 report (Feb 5, 2026: ~$141) — book-to-bill back above 1 in all three regions broke the multi-year range. (6) The AI/data-center story and the Microsoft Frontier designation (June 2026) carried it to ~$191 before Q1 even printed. (7) The Q1’26 blowout (reported May 7) — revenue +39%, non-GAAP EPS $5.22 (+190%) — plus a new $1B buyback confirmed the trend and drew momentum flows to a 52-week high of $237; the stock has since eased to ~$215. Every price move here is a Fact; the attributed cause is Interpretation.

1. Executive Summary

Arrow Electronics is the world’s #1 or #2 broad-line distributor of electronic components, paired with a top-three Enterprise Computing Solutions (ECS) IT-distribution arm. FY2025 revenue was $30.9B: Global Components $21.5B (69.7% of sales) and Global ECS $9.4B (30.3%). It is a ninety-year-old, Fortune-154, investment-grade business with ~22,230 employees and one of the two broadest supplier line cards on earth — a genuine, hard-to-replicate scale barrier to entry.

It is also, by the cold logic of its financials, one of the lowest-quality business models in all of distribution. Consolidated operating margin is ~3% (GAAP 2.7% in FY2025), return on invested capital sits at ~8% — roughly its own cost of capital — and management’s proxy discloses a three-year average ROIC-minus-WACC spread of just 1.11%. Growth is not the problem; economics are. Arrow has scale without pricing power: revenue is booked order-by-order with a few months’ visibility, no customer exceeds 2% of sales, no supplier 8%, and distributor agreements are non-exclusive and cancellable. This is a franchise whose moat protects volume, not returns.

The business is violently cyclical. Revenue swung from a $37.1B shortage-era peak (2022) to a $27.9B destocking trough (2024) and has recovered to $30.9B (2025), with a sharp reacceleration into 2026: Q1’26 revenue rose 39% year-over-year to $9.5B and non-GAAP EPS jumped 190% to $5.22, driven by a broad components restock plus AI/data-center demand flowing through ECS. Management guides Q2’26 revenue +25% but non-GAAP EPS down sequentially to $4.32–4.52 — a signal that Q1 was flattered by transient items (four extra shipping days, a hyperscaler pull-forward) and that the recovery, while real, is volume-led and mix-diluted (both segments lost 50–60bps of operating margin in a rising-revenue year).

Two quality-of-earnings features deserve emphasis. First, accounts receivable ballooned 51% to $19.7B at year-end 2025 (DSO ~234 days) — not channel stuffing, but the pass-through of Supply Chain Services intermediation for hyperscaler data-center builds, in which Arrow manages the associated AR and AP flows and increasingly funds them via securitization and factoring. It crushed FY2025 operating cash flow to $64M. Second, cash generation is counter-cyclical: Arrow generated $1.0B of free cash flow in the 2024 downturn and burned cash in the 2025 recovery, because growth consumes working capital.

Capital returns are 100% buyback (no dividend), and Arrow has retired ~33% of its shares in five years — but the cadence was pro-cyclical, spending $1.05B at the 2022 peak and only $162M at the 2025 trough. Governance carries two live flags: CEO Sean Kerins departed abruptly in September 2025 with no severance and full equity forfeiture (no cause stated), and the permanent-CEO search continues under an interim leader from outside the industry.

The investment tension is entirely about price, not quality. A year ago Arrow was a distressed-value cyclical at ~$110 and 0.86x book; today at ~$215 it sits at ~1.7x book and the ~91st percentile of its own decade-long valuation range — richest-ever on price-to-sales. The market has already underwritten the recovery. The remainder of this memo argues that Arrow is a good franchise, a bad industry, and a fully-priced-to-expensive stock.

2. Business Overview

Arrow Electronics operates two reportable segments that are, in economic substance, two different companies stapled together by a shared logistics and credit backbone.

Global Components (FY2025 sales $21,501M, 69.7% of total; GAAP operating income $775M, 3.6% margin). This is the classic electronic-components distribution business: Arrow buys semiconductors and interconnect/passive/electromechanical (“IP&E”) parts from manufacturers and resells them, with associated engineering and supply-chain services, to a fragmented base of original-equipment manufacturers (OEMs), electronic-manufacturing-services firms (EMS), and contract manufacturers. The FY2025 product mix inside components is roughly 72% semiconductors and related services, 16% IP&E (capacitors, resistors, power supplies, relays, switches, connectors), 7% computing and memory, and 5% other. The value Arrow adds beyond pure logistics is “demand creation” — field application engineers who register designs that embed a supplier’s parts into a customer’s future product, plus supply-chain services (procurement, inventory management, kitting) and engineering/integration. IP&E surpassed $1B of quarterly revenue for the first time in Q1’26 and is a deliberately-cultivated, higher-margin sub-mix.

Geographically, components has tilted decisively toward Asia: FY2025 Americas $6,944M (22.5% of total company sales), EMEA $5,671M (18.4%), and Asia/Pacific $8,886M (28.8%) — now the largest and fastest-growing region (+12.1%). This matters because Asia/Pacific “generally has lower margins,” so the mix shift is a structural headwind to blended profitability even as it drives volume.

Global Enterprise Computing Solutions / ECS (FY2025 sales $9,352M, 30.3% of total; GAAP operating income $426M, 4.6% margin). ECS is an IT-channel distributor: it sources datacenter, hybrid-cloud, storage, security, software, and data-intelligence solutions from vendors and sells them through value-added resellers (VARs) and managed service providers (MSPs). Its ArrowSphere digital platform lets partners source, provision, manage, and bill multi-cloud and subscription technologies — the most moat-like asset in the portfolio, though Arrow discloses no GMV, take-rate, or attach metrics. The FY2025 ECS product mix is ~27% software applications, 25% storage, 15% security, 14% compute, and the balance in data intelligence, networking, and services.

A crucial accounting nuance governs how to read ECS “growth”: Arrow reports net sales of $9,352M against gross billings of $22,050M, meaning roughly 58% of ECS volume is recognized on a net (agent) basis — Arrow books only the fee, not the full ticket, when it merely arranges a third party’s software, cloud, or warranty. It recognizes gross (principal) only when it bears fulfillment responsibility and inventory risk. A mix shift toward gross recognition — which is exactly what happened in 2025 as hardware demand surged — inflates reported ECS revenue without a corresponding change in gross profit. Anyone modeling ECS on headline revenue growth will overstate its economic contribution.

How Arrow makes money, in one sentence: it earns a thin spread (blended ~11% gross margin, ~3% operating margin) on an enormous flow of components and IT hardware/software, financing customers’ working capital in the process, and converts that into per-share value primarily by shrinking the share count. Revenue is overwhelmingly transactional and non-contracted; the recurring-revenue element (ArrowSphere subscriptions, some ECS software) is growing but undisclosed in magnitude. Verdict: a genuinely large, diversified, well-run distribution platform — but a transactional, spread-based, working-capital-intensive one, not a recurring-revenue compounder.

3. Industry Dynamics

Arrow sits in the thinnest-margin link of two distinct value chains. In components: semiconductor and IP&E suppliers → distributor (Arrow, Avnet, plus Asia’s WT Microelectronics/WPG and catalog specialists Mouser and Digi-Key) → OEM/EMS/contract manufacturers. In ECS/IT: technology vendors → distributor (Arrow ECS, TD SYNNEX, Ingram Micro) → VARs/MSPs → end users. Both chains are oligopolistic at the top and consolidating — WT Microelectronics acquired Future Electronics, reshaping the Asian line-card landscape — but that consolidation protects a structurally low-return profit pool rather than creating pricing power.

Why components distribution is the worst corner of distribution. Set against the broader distribution sector, the ranking of distribution economics is stark. Best-in-class models — Watsco in HVAC (28% gross, 9.6% operating, 15–27% ROIC, net cash), Applied Industrial in MRO/fluid power (30% gross, 11% operating, ~17% ROIC), CDW in IT solutions (~7% operating, ~15% ROIC) — earn durable, high returns because they hold power over fragmented suppliers, sell technical/consumable products with real switching costs, and enjoy replacement/annuity demand. Electronic-components distribution is the mirror image on four dimensions:

1. Commodity pass-through, no pricing power. Arrow resells chips designed by TI, Analog Devices, NXP, and ST on a cost-plus spread. It owns no product IP; competition “creates pricing pressure and the need to continually improve services,” in the 10-K’s own words.
2. Inverted supplier power. A handful of giant semiconductor makers own the line cards, set rebate and margin terms, dual-source their distributors, and can go direct on large accounts — so the distributor is disintermediable precisely on its highest-volume business. Arrow notes it “also competes for customers with its suppliers.”
3. Highest working-capital intensity in distribution. Long lead times, book-to-bill volatility, and inventory-obsolescence risk (parts get designed out) force the distributor to float inventory and receivables for under-capitalized customers. Cash flow is deeply counter-cyclical.
4. Brutal cycle amplitude. Revenue swung ~25% peak-to-trough ($37.1B → $27.9B) on a ~3%-operating-margin base, so operating leverage cuts hard both ways. Avnet’s diluted EPS collapsed 67% ($8.26 → $2.75) across the same downcycle. No industrial distributor swings like this.

The secular tailwind is real: semiconductor content per device rises over time, and AI/data-center build-out is now an incremental demand driver (“demand for components will continue to gradually increase aided by the market focus on AI technology”). But the cyclical whipsaw dominates the secular drift on any horizon shorter than a decade. In Marathon capital-cycle terms, the 2020–22 shortage pulled demand and capital forward into the channel; 2023–24 was the supply-side purge; Arrow is now early in the recovery leg. New structural pressures include tariffs (which mechanically inflate both revenue and COGS), a Q4’25 U.S. entity-list incident that caused marginal Asia/Pacific lost sales, and competition from logistics and e-commerce supply-chain entrants.

Verdict: a structurally mediocre industry. High barriers to entry protect incumbents’ volume, but they protect a low-return, capital-hungry, deeply cyclical profit pool that is perpetually squeezed between powerful suppliers upstream and, increasingly, hyperscalers who can bypass distribution entirely. Not a good industry to own through the cycle at a premium multiple.

4. Competitive Position

Arrow’s moat, in Greenwald’s taxonomy, is economies of scale plus modest, SKU-level switching costs — a real barrier to entry that conspicuously fails to convert into excess returns. The single most damning datapoint is Arrow’s own: its 2023–2025 performance share units, gated on three-year average ROIC-minus-WACC and relative EPS growth, vested at only 50% of target, because its EPS growth “ranked ninth among the reporting companies” and its ROIC exceeded WACC by just 1.11%. A ~1.1% economic-value-add spread is the textbook fingerprint of scale-without-pricing-power. When a self-declared moat cannot be tied to a financial outcome that would deteriorate without it, it is, in Greenwald’s framing, a franchise in name only.

Running the tests:

• Scale and scope (the genuine advantage). ~140 sales facilities, 39 distribution and value-added centers, operations in 85+ countries, and one of the two broadest line cards globally. A new entrant cannot cheaply replicate the combination of global logistics, thousands of supplier authorizations, and the balance-sheet capacity to extend credit to a fragmented customer base. This is a real barrier — but it caps downside (hard to displace) rather than creating upside (no pricing power).
• Supplier switching costs (weak). Distributor agreements cover 56% of inventory with price-protection and stock-rotation rights and 59% with repurchase-on-termination rights — genuinely de-risking Arrow’s inventory and making it a valued channel — but the agreements are “typically non-exclusive and cancellable by either party at any time or on short notice.” Little durable lock-in.
• Customer switching costs / design-win stickiness (the best element, but narrow). Field-application-engineering “demand creation” registers designs that embed suppliers’ parts into customers’ future products, which “generally leads to longer and more profitable relationships.” This is real captivity — but at the designed-in-SKU level, not the account level, and “substantially all of the company’s sales are made on an order-by-order basis, rather than through long-term sales contracts,” with only a few months’ visibility.
• ArrowSphere / network effects (unproven). The digital platform could raise ECS switching costs for VARs and MSPs through subscription management and multi-cloud orchestration. It is the most moat-like asset Arrow owns, but with no disclosed economics its contribution is an open question, not an established advantage.

Head-to-head with Avnet (the mirror twin). Arrow is ~30% larger ($30.9B vs $22.2B revenue), with slightly better gross margin (11.2% vs 10.7%), operating margin (3.0% vs 2.8%), and ROIC (~8% vs 7.6%). The decisive difference is ECS: Arrow kept its ~$9B IT-distribution arm — riding the same AI-infrastructure tailwind re-rating TD SYNNEX and WESCO — whereas Avnet sold its IT-distribution business to Tech Data in 2016 and is now pure components-plus-Farnell. That optionality justifies Arrow’s premium to Avnet (1.65x vs 1.30x book). But strip out ECS and Arrow’s ~70% components core is Avnet’s business — the identical structurally-worst-in-distribution model. That the two are factor-siblings (0.90 similarity), and that Arrow’s #1 statistical cousin is literally a value-factor ETF, confirms the market still fundamentally reads Arrow as a deep-value cyclical.

Verdict: a defensively wide but offensively narrow moat. Real barriers to entry, low returns for any would-be entrant, but no pricing power and order-by-order revenue for the incumbent. A crowded, commoditized market in which Arrow’s differentiation (scale, design services, ECS/ArrowSphere) earns it a marginal edge over Avnet and roughly its cost of capital — not a durable excess-return franchise.

5. Growth History and Forward Opportunities

Arrow’s five-year revenue path is a cycle, not a trend: $28.7B (2020) → $34.5B (2021) → $37.1B (2022 peak) → $33.1B (2023) → $27.9B (2024 trough) → $30.9B (2025). Diluted EPS traced a wider arc — $7.43 → $15.10 → $21.80 → $15.84 → $7.29 → $10.93 — amplified in both directions by operating leverage on a thin margin and by the shrinking share count. Over the full five years, revenue compounded at a pedestrian ~1.5% while EPS compounded ~8% — almost entirely a function of buybacks, not organic growth.

The current upcycle is genuine and broad. Quarterly revenue reaccelerated through 2025 into a Q1’26 print of $9.5B, +39% year-over-year — the sharpest sequential slope in the dataset:

*Revenue and margins per ROIC.ai quarterly data reconciled to releases; Q2’26 is the guidance midpoint ($9.15–9.75B revenue; non-GAAP EPS $4.32–4.52). Note the operating-margin climb from 2.6% to 4.2% across five quarters — the operating leverage management emphasizes — and the guided Q2 EPS step-down that signals Q1 was a local high. Management describes a “broad-based” recovery across geographies, verticals, and customer types, “fundamentally unit-volume-driven backed by customer demand” rather than price — an important distinction, because a price-driven restock (customers front-running component inflation) would be lower-quality and prone to reversal. Book-to-bill sits above parity in all three regions, backlog is building into H2, and lead times are extending modestly (but nowhere near shortage levels). The two largest verticals — industrial and transportation — grew double digits sequentially in both the Americas and EMEA, and mass-market demand (a lagging, higher-margin cohort) is returning.

Forward opportunities cluster in three areas: (1) AI/data-center, flowing through ECS (compute, storage, networking, cloud) and through components supply-chain services for hyperscalers — the incremental driver of 2026 strength; (2) value-added services — supply-chain, engineering/design, and integration services that management says “grew as a share of total operating income” (roughly 30% of segment operating income last year, per the Q1 call) and carry higher, more durable margins; and (3) secular semiconductor content growth across the six core verticals (industrial, transportation, aerospace & defense, medical, consumer, data center).

Two cautions temper the growth story. First, quality: both segments lost 50–60bps of operating margin in 2025 despite rising revenue, because the mix shifted toward lower-margin Asia/Pacific components and gross-basis ECS hardware. The recovery is volume-led and margin-dilutive, not a structural profitability step-up. Second, durability: management’s own Q2’26 guide has revenue +25% but non-GAAP EPS stepping down to $4.32–4.52 from Q1’s $5.22, as the four-extra-shipping-days benefit and a one-time hyperscaler pull-forward reverse and compensation costs rise — a candid admission that Q1 was a high-water quarter, not a new run-rate. Verdict: real, broad, but cyclical and low-margin growth — high in magnitude right now, medium in quality, and unlikely to compound at anything like the current pace once the restock normalizes.

6. Financial Quality

The following five-year snapshot frames this section — a cyclical revenue line, a wildly amplified EPS line, cost-of-capital returns, and counter-cyclical cash generation, all filtered through a relentlessly shrinking share count:

Revenue, EPS, share count, and net debt/EBITDA reconciled to 10-K filings; ROIC/ROE per ROIC.ai. The EPS amplitude (a ~3x peak-to-trough swing on a ~25% revenue swing) is the operating-leverage-on-a-thin-margin signature of the model; FCF turning negative in the up-years (2022, 2025) is the counter-cyclical working-capital signature.

Margins are thin and structurally so. GAAP gross margin ran 11.1% (2020) to a 13.0% shortage-era peak (2022) and back to 11.2% (2025); GAAP operating margin was 2.7% in FY2025 (non-GAAP 3.1%) versus a 5.6% peak in 2022. Q1’26 lifted GAAP operating margin to 4.2% — the best in the dataset — on volume leverage, but management guides it back down in Q2. Both reportable segments run structurally low: components ~3.6% and ECS ~4.6% operating margins, both compressing year-over-year in 2025 on mix. This is a business where scale delivers cost efficiency but not margin expansion; the incremental dollar of revenue is low-margin, and mix (Asia, gross-basis ECS) keeps diluting the blend.

Returns hover at the cost of capital. ROIC (per ROIC.ai) ran 9.4% → 16.0% → 18.5% (2022 peak) → 12.9% → 8.0% → 8.1% (2025); ROE was 9.0% in 2025. Management-cited Q1’26 figures are cyclically better (ROIC 13.4%, return on working capital 23.1%), but the through-cycle average is the tell, and the proxy pins the 2023–25 ROIC-minus-WACC spread at 1.11%. For a capital allocator, this is the crux: Arrow creates only marginal economic value per dollar deployed, so per-share value creation must come from financial engineering (buybacks) rather than reinvestment.

Cash generation is counter-cyclical and, in growth years, weak. Free cash flow was +$1.24B (2020), +$0.34B (2021), −$0.11B (2022), +$0.62B (2023), +$1.04B (2024), and −$0.04B (2025). The pattern is diagnostic: Arrow releases cash in downturns (working capital unwinds) and consumes it in recoveries (working capital builds). FY2025 operating cash flow collapsed to just $64M as accounts receivable and inventory ballooned to fund the recovery — a normal feature of the model, but one that means the current upcycle will be cash-hungry, constraining buyback capacity exactly when the stock is expensive.

The receivables balloon — explained, but worth watching. Accounts receivable jumped 51% to $19.7B at year-end 2025 (from $13.0B), pushing DSO to ~234 days — a figure that would be alarming for a normal distributor. It is not channel stuffing: the 10-K and the Q1 call explain that Arrow’s Supply Chain Services intermediate hyperscaler data-center procurement, in which Arrow “manages the associated AR and AP flows” within existing customer-supplier relationships, carrying disproportionate receivables against a matching accounts-payable balance, with the underlying inventory consigned (not owned). The allowance for credit loss is a modest 0.7% of AR, and Arrow increasingly funds these flows via a North American securitization ($1.5B capacity, $970M drawn), an EMEA securitization (€600M, off-balance-sheet), and trade-receivable factoring. So the balloon is a working-capital-light, low-margin flow-through — but it introduces genuine risks: hyperscaler counterparty concentration, large quarter-end swings that make any single period’s cash flow noisy, and off-balance-sheet financing that flatters reported leverage.

Working capital is the whole cash-flow story. Arrow’s cash conversion cycle ran ~50 days in 2020–21, widened to ~72–79 days in 2023–25 as receivables lengthened, and is the swing factor behind every year’s free cash flow. The mechanics are simple but easy to miss: in a recovery, Arrow must pre-fund inventory and extend receivables to serve rising demand (it is, at its core, a credit provider to under-capitalized customers), so cash is consumed even as earnings rise; in a downturn, that working capital unwinds into cash. This is why FY2024 — a falling-revenue year — produced $1.04B of free cash flow, while FY2025 — a rising-revenue year — produced negative FCF. The SCS/hyperscaler AR/AP flow-through has amplified the receivables line specifically, but the underlying counter-cyclical dynamic is structural and permanent. For valuation, the implication is that the current upcycle will be cash-hungry (constraining buybacks precisely when the stock is dear), and that the “quality” of any single year’s cash flow must be judged against where that year sits in the cycle.

Balance sheet: investment-grade and comfortable. Year-end 2025 gross debt was $3.1B against $0.3B cash — net debt $2.8B, or 2.58x trough EBITDA (closer to ~1.6x on a forward basis as EBITDA recovers). EBITDA-to-interest coverage is 5.0x. Book value per share is $127.56 and tangible book (after $2.2B goodwill) is ~$86. Capex is minimal (~$100M, ~0.3% of sales), so the business consumes capital through working capital, not fixed assets. Dilution is negligible — stock-based compensation runs ~$28–43M/year against a share count Arrow is actively shrinking. Verdict: economics do not meaningfully improve with scale. Arrow is financially sound and well-managed, but it is a low-margin, low-return, cash-generative-only-in-downturns business whose reported earnings and cash flows must be read across the full cycle, not off a single flattering quarter.

7. Capital Allocation

Capital allocation at Arrow is, in practice, one lever: the buyback. There is no dividend. Over five years Arrow retired roughly a third of its shares — diluted count fell from 78.6M (2020) to 52.3M (2025) — which is the primary engine of its ~8% EPS CAGR against ~1.5% revenue growth. The direction is shareholder-friendly; the timing is the problem.

The cadence was pro-cyclical. Cash-flow repurchases ran $1,049M (2022) → $770M (2023) → $265M (2024) → $162M (2025). Arrow spent the most buying its own stock at the 2022 revenue and price peak and cut repurchases ~85% into the 2024–25 trough, when the shares were cheapest (it bought 2025 stock at ~$115 and 2024 at ~$125, both below the ~$130 book value but well above the ~$90 low). This is the textbook value-destructive pattern — heavy at the top, light at the bottom. In fairness, the 2025 pullback was partly forced: operating cash flow collapsed to $64M as working capital absorbed the recovery, so buyback capacity was genuinely constrained, not merely mistimed. And the timing signal cuts the other way now — Arrow authorized a fresh $1B program in May 2026 and repurchased only $25M in Q1’26, sensibly holding back at a doubled share price. Grade: mediocre, not egregious — the right instrument, the wrong cadence, with a mitigating cash constraint.

M&A has been minimal, clean, and un-impaired. Total goodwill of $2.2B has never been written down (2023/2024/2025 impairment tests all clean). The only 2025 acquisition was a $35M immaterial tuck-in; the largest legacy deal, eInfochips (India design/engineering services, ~$280M in 2016), carries $226M of never-impaired goodwill. There have been no large, ego-driven, value-destructive acquisitions in the window — a genuine positive, and a favorable contrast to serially-acquisitive peers whose roll-ups have produced negative tangible book and impairment risk.

Reinvestment is light and leverage is managed. Capex is ~0.3% of sales; the business is asset-light and consumes capital through receivables and inventory. Arrow actively terms out and redeems debt ($350M redeemed 2025, $1.0B in 2024), maintains investment-grade metrics and covenant compliance, and funds the receivables surge through securitization and factoring. A restructuring “Operating Expense Efficiency Plan” (~$200M total, $116M booked in 2025) is driving the operating-leverage story management emphasizes — real cost discipline, though it complicates GAAP comparability.

Verdict: competent, not exceptional. Disciplined on M&A (no impairments, no empire-building), asset-light, and IG-prudent — but the single-lever, pro-cyclical buyback forfeited the counter-cyclical opportunity to retire shares at the trough, and the growing reliance on off-balance-sheet securitization to fund working capital deserves ongoing scrutiny. Management allocates capital sensibly within a low-return business; it has not found a way to make the business itself high-return.

8. Changes and Headwinds — Last Two Years

The cycle turned. The defining change is the transition from the 2023–24 destocking recession to the 2025–26 recovery. Components entered a cyclical downturn in 2023 that endured through 2024 and into 2025 (elevated customer inventories unwinding after the shortage normalized), then reaccelerated sharply from late 2025: book-to-bill back above 1 in all regions, building backlog, and modestly extending lead times. This is the proximate driver of the ~100% stock move and of the Q1’26 blowout (revenue +39%, non-GAAP EPS +190%).

AI/data-center became a real revenue driver. ECS is now heavily exposed to AI-server and infrastructure demand (compute, storage, networking, cloud, security), and components supply-chain services benefited from hyperscalers pulling forward data-center builds — including one hyperscaler accelerating a build into Q1’26. Arrow earned the Microsoft “Frontier” AI-cloud distributor designation across EMEA and North America (June 2026) and launched Global Experience Centers to accelerate AI/cloud adoption. Importantly, Arrow does not resell GPUs or CPUs — its AI exposure is the surrounding infrastructure and services, not the accelerators themselves, and memory is only mid-single-digits of components revenue.

Leadership discontinuity. CEO Sean Kerins separated as President/CEO and director on September 16, 2025, after only ~3 years, with no severance, all unvested equity and cash incentives forfeited (including a $7M LTIP grant), and no cause stated. A clean-break, full-forfeiture exit of a sitting CEO is atypical for an ordinary retirement and is more consistent with a board-initiated departure. Board member William (Bill) Austen — former CEO of Bemis (packaging, not electronics) — was named interim CEO the same day and has stated he does not intend to serve long-term; the permanent-CEO search continues. This is the third CEO in a few years (Long → Kerins → Austen) and a live overhang.

Other developments. A Q4’25 U.S. Bureau of Industry and Security entity-list incident caused marginal Asia/Pacific lost sales; tariffs mechanically raise both revenue and COGS and add planning complexity; the restructuring “Operating Expense Efficiency Plan” is delivering the operating-leverage that lifted Q1’26 incremental margins. On governance, 2026 compensation added a relative-TSR metric for all NEOs (a shareholder-friendly upgrade), and the board is advancing proposals to eliminate supermajority-voting provisions.

Verdict: the operating changes strengthen the near-term thesis, the structural and governance changes complicate it. The cyclical recovery and AI tailwind are genuine positives; the margin dilution, the receivables balloon, and above all the abrupt CEO exit under an interim, out-of-industry leader are meaningful qualifications that the ~100% re-rating has largely ignored.

9. Risk Analysis

The dominant risks are not solvency risks — Arrow is investment-grade and diversified — but cyclical and valuation risks that compound each other. The stock is priced for the recovery to continue at a peak multiple; a rollover in book-to-bill would hit earnings and the multiple simultaneously. The idiosyncratic risks (receivables reversal, CEO vacancy, supplier disintermediation) are second-order but real. A catastrophic or total loss is highly unlikely.

10. Valuation Discussion (Embedded Expectations)

At ~$215, Arrow’s ~51M shares imply a market capitalization of ~$11.0B and, with ~$2.8B net debt, an enterprise value of ~$13.8B. The headline multiples look modest in isolation — EV/Sales ~0.44x, EV/EBITDA ~10x on trailing/~8x on normalized EBITDA, P/E ~15x trailing GAAP (~11x on 2026 forward non-GAAP EPS of ~$19), P/B ~1.7x, P/TBV ~2.5x. The bull case rests entirely on “only ~11x forward earnings.” Two lenses show why that is misleading.

Lens one — versus peers, Arrow is appropriately cheap for its quality, not mispriced. Arrow’s ~8x EV/EBITDA is the lowest screen in the distribution comp set (CDW 11.8x, WESCO ~12.5x forward, Watsco ~19x, Applied Industrial ~22x), but so is its return profile: ~8% ROIC versus 15–17% at Watsco/Applied/CDW. A business that earns its cost of capital should trade at ~8x EBITDA — the low multiple is the market correctly pricing structurally inferior returns, not a discount to be arbitraged. On a quality-adjusted basis, Arrow is not cheap relative to peers; it is appropriately the cheapest.

¹ SNX/CDW book distorted by acquisition goodwill; P/B not meaningful. ² CDW gross margin inflated by net-revenue (agency) accounting. Peer figures from public filings and market data (June–July 2026); AVT fiscal year ends June.

Lens two — versus its own history, Arrow is expensive. This is the tell the peer screen hides. Arrow sits at the ~91st percentile of its own ten-year valuation range, with price-to-sales at the 99th percentile — the richest reading in the company’s history. A year ago, at ~$110, it traded at 0.86x book; today at ~$215 it trades at ~1.69x — book value roughly doubled with the price. On the metric that actually works for a components distributor — price-to-book, because GAAP EPS is cyclically distorted and book is real net working capital — Arrow is not trough-cheap; it is at a peak multiple on recovering earnings. Its historical P/B band was roughly 0.7x–1.3x; 1.69x is well outside it.

The re-rating is starkest in Arrow’s own multiple history. Note how price-to-book and EV/Sales — the metrics that work when GAAP EPS is cyclically distorted — have expanded to well beyond anything in the prior five years, even as the P/E “looks” ordinary:

FY-end figures per ROIC.ai valuation multiples; “Now” per current price. The P/E is uninformative here because it is measured against cyclically-distorted GAAP EPS (note 2024’s 15.4x on trough earnings vs 2022’s 4.8x on peak earnings — the classic inverse). P/B and EV/Sales tell the real story: both are at multi-year highs, and the AZI own-history engine puts P/S at the 99th percentile of a full decade.

What the current price embeds. For $215 to be justified, the market is capitalizing (a) a durable components-cycle upturn after the Avnet-style earnings collapse, (b) continued double-digit ECS/AI-driven growth, and © an operating-margin recovery toward mid-cycle (3% → ~4%+) that sticks. Reframed honestly: ~11x “forward” is ~15x trailing and, on normalized mid-cycle EPS of ~$12–15, roughly ~14–18x — a full multiple for a business earning its cost of capital. The 1.69x P/B says the market has already underwritten the recovery; the distressed-to-fair-value re-rating (the easy money, from 0.86x to book) is made. From here, an investor is no longer paid to wait for the cycle — at the richest multiple in company history, they are paying up for a cyclical recovery to arrive on schedule in the worst-economics corner of distribution.

A normalized-earnings frame makes the trap explicit. Over the last full cycle (2020–2025) Arrow’s diluted EPS averaged ~$13.1, but that average blends a much larger historical share count (78.6M in 2020) with today’s 52.3M. Re-basing to the current count and a normalized ~$0.75–0.80 net margin on ~$31–33B of mid-cycle revenue implies mid-cycle earnings power of roughly $12–15 per share — below the ~$19 forward number the bulls capitalize. At $215, that is ~14–18x normalized earnings, versus a historical median P/E closer to ~9–10x. Put differently: the stock is being valued as though 2026’s recovery run-rate is the new baseline, when the company’s own guidance (Q2 EPS stepping down) and the structural mix headwinds (Asia, gross-basis ECS) argue it is nearer a local high. The bull is paying ~11x for peak-ish earnings; the skeptic sees ~15x for normalized earnings in an 8%-ROIC business — and history says the multiple, not just the E, is what re-rates when the cycle turns.

A bear/base/bull sketch (illustrative, not a target): a bear case reverts the multiple toward its historical ~1.0–1.1x book and normalizes EPS toward ~$12 as the restock fades — a materially lower valuation; a base case holds ~11–12x on ~$18–19 forward EPS and roughly the current zone if the upcycle persists a few years; a bull case sees value-added services and ECS/AI structurally lift through-cycle operating margin toward 5%+ and earn a durable re-rate to ~13–14x on higher normalized earnings. The distribution of outcomes is skewed by where we sit in the cycle: at a peak multiple on recovering earnings, the asymmetry favors the downside. No price target; no recommendation.

11. Variant Perception

Consensus. The sell-side and screening consensus is bullish and, unusually, spans two normally-opposed camps: Arrow screens as a Zacks #1 “Strong Buy” value stock (cheap on trailing/forward P/E and P/S) and as a top-ranked momentum stock (52-week highs, +100% YTD). The narrative is “an AI stock at a value price” — real AI/data-center demand, an aggressive buyback halving the share count over a decade, and “only ~11x forward earnings.” Recent trade-press pieces prefer Arrow to Avnet for its ECS/AI optionality.

The strongest bull case. The components cycle has turned decisively (book-to-bill >1 in all regions, building backlog), the AI/data-center tailwind gives Arrow a genuinely new secular driver through ECS and supply-chain services, the restructuring has built real operating leverage (Q1’26 incremental margins were high, OpEx grew at a third the rate of revenue), value-added services are structurally lifting margin and earnings quality, and the buyback compounds per-share value on a shrinking count. If through-cycle operating margin steps up toward 5% and the upcycle runs multiple years, ~11x forward is cheap and the stock re-rates further.

The strongest bear case. Arrow is a ~3%-operating-margin, ~8%-ROIC commodity distributor — the structurally worst model in distribution, with a self-disclosed 1.11% ROIC-over-WACC spread — that has re-rated ~100% to the richest multiple in its history (91st-percentile composite, 99th-percentile P/S) precisely as earnings hit a cyclical-recovery high. The “value” screen is an artifact of measuring a peak-multiple cyclical against recovering earnings; the “momentum” is a crowded late-cycle trade in a name whose factor identity is deep value. The recovery is volume-led and margin-dilutive (both segments lost margin in 2025), the Q2 guide already steps EPS down, the receivables balloon and off-balance-sheet securitization introduce working-capital and counterparty risk, and the company is being run by an interim CEO after an abrupt, unexplained, no-severance departure. When book-to-bill rolls over — as it always eventually does — earnings and the multiple compress together.

The 3–5 assumptions that matter most. (1) Is 2026 a mid-cycle year with room to run, or a cyclical-recovery high near the top? (2) Do value-added services and ECS/AI structurally lift through-cycle operating margin, or is the 2025–26 improvement just operating leverage that reverses in the next downturn? (3) Does the SCS-driven receivables balloon stay benign (matched AP, consigned inventory) or reverse into a working-capital/counterparty shock? (4) Does the permanent-CEO appointment bring continuity or disruption? (5) Does the multiple hold at ~1.7x book, or mean-revert toward its 1.0–1.3x history?

The factor-positioning read. FactorsToday classifies Arrow as a high-beta (0.8–0.9) value cyclical — positive loadings on value-proxy and semiconductor factors, negative on low-volatility (anti-defensive), and no momentum loading yet (the three-year window is still dominated by the pre-2026 range). Its nearest factor-cousins are a value ETF and Avnet. Yet its recent risk-adjusted record is an extreme outlier: a 6-month annualized Sharpe of 5.6 on a ~+82% move, against a ten-year annualized return of only ~13% and a −73% lifetime drawdown. This is precisely the fingerprint of a low-quality, high-volatility value name having a violent momentum run — evidence that consensus is offsides not on direction (the recovery is real) but on price and durability: the market is extrapolating a cyclical-recovery quarter into a compounder multiple in the worst corner of distribution.

12. Fact vs. Interpretation

13. Open Questions

1. What actually caused the CEO change? No cause was stated for Kerins’s no-severance, full-forfeiture exit. Was it performance, strategy, conduct, or a board-strategy disagreement — and what does the eventual permanent hire signal about future direction (double-down on ECS/AI, or refocus on components)?
2. What are ArrowSphere’s economics? GMV, take-rate, attach rate, and recurring-revenue contribution are undisclosed. This is the difference between “distributor with a portal” and “platform with switching costs.”
3. How much of Q1’26 was durable? Beyond the quantified four-extra-days and hyperscaler pull-forward, how much of the +39% is a sustainable run-rate versus a restock/pre-buy spike? Is there double-ordering in the backlog as component prices rise?
4. Where does through-cycle operating margin settle? Is the 2025–26 improvement structural (value-added-services mix, permanent cost takeout) or cyclical operating leverage that reverses in the next downturn?
5. How large and concentrated is the SCS/hyperscaler flow-through, and how does it behave in reverse? What happens to the $19.7B receivable and the securitization draws if a major hyperscaler build slows?
6. What is normalized EPS on the current share count? The market’s “11x forward” and a bear’s “15x normalized” differ entirely on this number; management provides no mid-cycle framework.

14. What Must Be True

Bull case — what must be true: (1) the components upcycle runs multiple years, not quarters, with book-to-bill holding above parity; (2) ECS/AI demand compounds durably and value-added services structurally lift through-cycle operating margin toward 5%+, re-rating the earnings quality; (3) the buyback continues to shrink the count meaningfully; and (4) the permanent CEO sustains strategy. If so, ~$18–20 of forward EPS is a durable base and ~11–14x is defensible.

Falsification test (bull): book-to-bill falls back below 1 in two or more regions, or two consecutive quarters show operating margin compressing back toward 3% despite flat/rising revenue (i.e., the “operating leverage” proves cyclical, not structural). Either would break the durable-earnings thesis.

Bear case — what must be true: (1) 2026 is at or near a cyclical earnings high, and normalized mid-cycle EPS is closer to $12–15 than $19; (2) the ~1.7x book / 99th-percentile P/S multiple mean-reverts toward its 1.0–1.3x history; (3) the volume-led, margin-dilutive recovery does not translate into a structural return step-up (ROIC stays ~8%). If so, the stock is expensive on normalized earnings and re-rates down as the cycle matures.

Falsification test (bear): Arrow sustains a through-cycle operating margin of ~5% and ROIC comfortably above WACC (say >12%) across a full cycle including a components downturn, and holds a >1.4x book multiple through that downturn. That would prove the value-added-services/ECS mix has genuinely re-rated the business’s economics, invalidating the “commodity cyclical at a peak multiple” thesis.

15. Source Appendix

See the Source Appendix (Appendix B) below for the full citation list. Primary sources: Arrow Electronics FY2025 Form 10-K (filed 2026-02-11) and FY2024 10-K; 2026 and 2025 DEF 14A proxy statements; Q1 2026 earnings call transcript (2026-05-07) and earnings release; SEC EDGAR XBRL facts and Form 4 filings (CIK 0000007536). Quantitative data: ROIC.ai (financials, ratios, enterprise value, valuation multiples), AZI trading (price history and own-history valuation percentiles), FactorsToday (factor loadings, risk-adjusted leaderboard, related stocks). Peer context: public peer filings on TD SYNNEX (SNX), CDW, WESCO (WCC), Applied Industrial (AIT), and Watsco (WSO); Avnet (AVT) financials via ROIC.ai. Trade press for recent events (BusinessWire, Seeking Alpha, Zacks, Reuters) validated against primary filings.

APPENDIX A — Standard Diligence Questionnaire

Supplemental to the analysis above. Fact / Interpretation / Assumption labels applied where material.

General

What thoughtful questions have other investors asked about this company? The recurring institutional questions: (1) Is the AI/data-center revenue durable or a restock/pull-forward spike? (Q1’26 call spent most of the Q&A here — management concedes four extra shipping days and a hyperscaler build pull-forward inflated Q1.) (2) Is the 51% receivables jump a credit-quality problem? (Answer: it is SCS hyperscaler flow-through, matched by AP, consigned inventory — Interpretation: benign but concentrated.) (3) Is Arrow better than Avnet? (Yes on ECS optionality and marginal economics, but the core is identical.) (4) What is normalized EPS, and is “11x forward” cheap or a cyclical trap? (5) Why did the CEO leave, and who replaces him?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Recovering off a 2024 trough toward a high — Interpretation: closer to a cyclical-recovery high than a mid-cycle base. Diluted EPS traced $21.80 (2022 peak) → $7.29 (2024 trough) → $10.93 (2025), with Q1’26 non-GAAP EPS $5.22 annualizing well above trailing; Q2’26 is guided down sequentially — a signal the run-rate is near a local high, not building further.

Driven by external environment or internal actions? Predominantly external (the semiconductor inventory cycle and AI/data-center demand), amplified by two internal levers: a ~$200M restructuring/cost-efficiency plan that built operating leverage, and a share count reduced ~33% in five years. Fact.

How stable are revenues? Unstable — ~25% peak-to-trough swing (2022 $37.1B → 2024 $27.9B) on a ~3% operating margin, so earnings swing far more. Revenue is transactional and order-by-order with only a few months’ visibility. Fact.

Outlook for products/services; how big is the market? Large and growing secularly (rising semiconductor content, AI infrastructure), but cyclical. Global electronic-components distribution and IT distribution are multi-hundred-billion-dollar TAMs; Arrow at ~$31B revenue is a scaled #1/#2 with low structural share growth (5-yr revenue CAGR ~1.5%). Growing, global, but the profit pool is thin and cyclical. Interpretation.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Consolidating at the top (WT Microelectronics acquired Future Electronics; ECS distribution concentrated among Arrow/TD SYNNEX/Ingram) but structurally commoditized, with rising disintermediation pressure from suppliers going direct and hyperscalers bypassing the channel. Net: rational oligopoly, but not less competitive on economics. Interpretation.

How profitable is the business (ROIC, ROE)? Low. ROIC ~8% (≈ cost of capital; 2023–25 ROIC-minus-WACC spread just 1.11% per the proxy), ROE 9.0% (2025). Fact.

How profitable is the industry; barriers to entry? The industry earns thin, cyclical spreads. Barriers to entry are genuinely high (global logistics, thousands of supplier authorizations, balance-sheet credit capacity) — but they protect a low-return profit pool. Watsco/Applied/CDW (15–17% ROIC) show what good distribution economics look like; components distribution (Arrow/Avnet, 7–9% ROIC) is the worst corner. Fact/Interpretation.

Can the business be easily understood? Yes — a spread-on-flow distributor with a buyback engine. The one subtlety is ECS gross-vs-net revenue recognition (58% net/agent) and the SCS receivables flow-through, which distort headline revenue and cash flow.

Undermined by foreign low-cost labor? Not directly (it is a distribution/logistics business, not manufacturing), but it is exposed to Asian competitors, tariffs, and US-China export controls (Q4’25 BIS entity-list incident). Fact.

Do brands matter? Nature of competition? Switching costs? Supplier brands (line-card breadth) matter more than the Arrow brand. Competition is on service, availability, credit terms, and design support. Switching costs are real only at the designed-in-SKU level (FAE demand creation) and potentially in ArrowSphere for ECS partners; at the account level they are weak (order-by-order, cancellable agreements). Interpretation.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? ArrowSphere’s platform value and the demand-creation/design-win franchise are unrecognized intangibles. Interpretation.

Off-balance-sheet liabilities? Yes and material to note: an EMEA receivables securitization (€600M, off-balance-sheet, ~$337M average) plus trade-receivable factoring, alongside the on-balance-sheet North American securitization ($1.5B capacity, $970M drawn). These fund the receivables surge and flatter reported leverage. Fact.

How conservative is the accounting? Broadly conservative on the core (0.7% AR allowance, goodwill never impaired, IG discipline), but non-GAAP adjustments (restructuring, amortization) and the gross-vs-net ECS recognition require care. The SCS AR/AP gross-up inflates the balance sheet. Interpretation.

How CapEx-hungry is the business? Very light on fixed capital (~$100M capex, ~0.3% of sales) but very heavy on working capital — growth consumes cash. Fact.

Capital Allocation & Management

How much FCF; how is it used; philosophy? FCF is counter-cyclical: +$1.0B in the 2024 downturn, −$0.04B in the 2025 recovery. Uses: 100% buyback (no dividend) plus debt management. Philosophy: return excess capital via repurchase while preserving IG. Fact. The cadence has been pro-cyclical (heavy at 2022 peak, light at 2024–25 trough).

Significant acquisitions recently? No — a $35M immaterial tuck-in in 2025; goodwill ($2.2B) never impaired; largest legacy deal eInfochips (2016, ~$280M). Clean, disciplined M&A. Fact.

Buying back shares? Yes, aggressively over time (~33% of shares in 5 years), though only $25M in Q1’26 (sensibly restrained at a doubled price) with a fresh $1B authorization (May 2026). Fact.

Issuing large amounts of stock to insiders? No — SBC is modest (~$28–43M/yr) against a shrinking count; dilution is negligible. Fact.

Compensation policy / motivations of management? Comp uses relative-EPS-growth and ROIC-minus-WACC PSUs (which vested at only 50% for 2023–25) plus a newly-added relative-TSR metric (all NEOs from 2026) — shareholder-aligned in design. Say-on-pay ~98%. But insider ownership is minimal (0.8% of shares outstanding) — alignment rests on comp design, not personal stakes. LTIP targets were raised toward peer median. Fact/Interpretation.

Valuation & Market Data

ADR / MLP / K-1? No — a US-domiciled C-corp, common stock, NYSE-listed. No K-1. Fact.

Dividend policy? None — Arrow pays no dividend; all capital return is via buyback. Fact.

How profitable is the business? Low-margin (GAAP operating margin 2.7% FY2025) but consistently profitable through the cycle; net income $571M (2025). Fact.

Is net income diverging from cash from operations? Yes, sharply and by design: FY2025 net income $571M vs operating cash flow of only $64M, because working capital (receivables, inventory) absorbed cash in the recovery. This is a normal counter-cyclical feature — cash exceeds income in downturns and lags it in recoveries — but it means a single year’s cash flow is not a clean earnings proxy. Fact.

Risks & Downside

What would cause the stock to decline? A components-cycle rollover (book-to-bill back below 1), a multiple de-rating from the current 99th-percentile P/S / 91st-percentile composite toward its history, a working-capital/receivables reversal, an AI-demand disappointment or pull-forward air-pocket, or a disruptive permanent-CEO outcome. Interpretation.

Risk of catastrophic loss? Low — diversified (no customer >2%, no supplier >8%), investment-grade, 90-year-old franchise, ample liquidity and interest coverage (5.0x). Fact.

Chance of a total loss? Very low. The realistic downside is a cyclical/valuation de-rate, not impairment of the enterprise. Interpretation.

Recent News & Events

Has the business environment changed recently? Yes — a decisive shift from the 2023–24 destocking recession to a 2025–26 broad-based recovery, with AI/data-center demand a genuine new driver (ECS billings +39%; hyperscaler supply-chain-services pull-forward; Microsoft “Frontier” AI-cloud distributor designation, June 2026; Global Experience Centers launched). Fact.

Significant acquisitions? None material. Fact.

Change in accounting policies? None flagged; ongoing gross-vs-net ECS recognition and SCS AR/AP flow-through are existing policies, not changes. Fact.

Recent changes — markets, facilities, management? The dominant change is leadership: CEO Sean Kerins departed abruptly in September 2025 (no severance, full equity forfeiture, no cause stated); William (Bill) Austen (ex-Bemis, board member) is interim CEO; the permanent-CEO search is ongoing. Also: a ~$200M restructuring/cost-efficiency plan, a Q4’25 US export-control (entity-list) incident affecting Asia sales, and a new $1B buyback authorization (May 2026). Fact.

APPENDIX B — Source Appendix

Arrow Electronics, Inc. (NYSE: ARW) — Research as of 2026-07-24

Fact / Interpretation / Assumption labels appear in the memo and diligence appendix. Primary sources are listed first, then quantitative-data services, then peer context and press. All quantitative figures were reconciled to SEC filings where possible; third-party aggregated data is labeled as such and is not primary.

1. Primary — SEC filings (SEC EDGAR, CIK 0000007536)

• Arrow Electronics FY2025 Form 10-K — filed 2026-02-11 (fiscal year ended 2025-12-31). Segment sales/operating income (Global Components $21,501M; Global ECS $9,352M net sales, $22,050M gross billings); geographic mix (Americas/EMEA/Asia-Pacific); product mix; revenue-recognition (gross vs. net) policy; receivables and Supply Chain Services disclosure; securitization/factoring programs; goodwill impairment tests; restructuring “Operating Expense Efficiency Plan”; risk factors; cyclical-downturn language…
• Arrow Electronics FY2024 Form 10-K — filed 2025-02-11 (prior-year comparatives, buyback/cash-flow history)…
• FY2021–FY2023 Form 10-Ks — mirrored for the trailing five-year corpus .
• 2026 DEF 14A proxy statement — filed 2026-03-30. CEO transition (Sean Kerins separation effective 2025-09-16, no severance, full forfeiture, no cause; William Austen interim appointment); executive compensation structure (relative-EPS-growth and ROIC-minus-WACC PSUs, 50% vesting for 2023–25 cycle, ROIC-WACC spread 1.11%, EPS growth ranked 9th; new relative-TSR metric); insider ownership (0.8% of shares); 5% holders (Vanguard, BlackRock, ACR Alpine Capital Research, Dimensional); governance proposals…
• 2025 DEF 14A proxy statement — filed 2025-03-25 (comp history baseline)…
• SEC EDGAR XBRL company facts / company concept — AccountsReceivableNetCurrent annual points 2018–2025 (AR $19.74B at YE2025 confirmed vs revenue $30.85B → DSO ~234 days); used to reconcile third-party data to filed values.
• SEC Form 4 filings (CIK 0000007536) — insider transactions ~2024–2026; standout: interim CEO William F. Austen open-market purchase of 3,960 shares at $151.87 on 2026-02-19 (~$601k, transaction code P; accession 0000007536-26-000062); remainder routine grants (A), option exercises (M), and tax-withholding/vest-driven sales (F/S).

2. Primary — Earnings materials

• Q1 2026 earnings call transcript — 2026-05-07. Interim CEO Bill Austen, CFO Raj Agrawal, segment presidents Rick Marano (Components) and Eric Nowak (ECS). Source of: revenue +39% to $9.5B; non-GAAP EPS $5.22 (+190%); components operating margin 5.5%; ECS billings $6.4B; four-extra-shipping-days and hyperscaler pull-forward explanation; SCS AR/AP flow-through mechanics and “material swings at quarter-end”; Q2’26 guidance (revenue $9.15–9.75B, non-GAAP EPS $4.32–4.52); book-to-bill above parity; “does not resell GPUs/CPUs”; memory mid-single-digit exposure; permanent-CEO search status; 2026 relative-TSR compensation.
• Q1 2026 earnings release — BusinessWire, 2026-05-07.
• Q2 2026 earnings call scheduled — August 6, 2026 (BusinessWire, 2026-07-23).

3. Quantitative data services (third-party aggregated; reconciled to filings)

• ROIC.ai — annual and quarterly income statements, balance sheets, cash-flow statements (FY2020–FY2025 + eight quarters); profitability, credit, per-share ratios; enterprise value and valuation multiples; company profile; company news; Q1’26 transcript. Also Avnet (AVT) financials and ratios (FY ends June). Third-party; not primary.
• AZI Trading — five-year daily price/OHLCV history (adjusted and unadjusted, EMAs, beta/alpha) via download-data.php?t=ARW; and the valuation_index own-history percentile ranks (at 2026-07-23, price $215.11: P/E 84th, P/B 89th, P/S 99th, composite 91st percentile of the stock’s ~10-year range).
• FactorsToday (factorstoday.com/api) — factor loadings (Market ~0.85, value-proxy/DividendYield, Technology/Semiconductor sector-industry, negative LowVolatility; momentum not yet loaded); risk-adjusted leaderboard (6-month annualized Sharpe 5.6 / ~+82% actual; 10-year return ~13%; lifetime max drawdown −73%); related-stocks (VLUE 0.94, LFUS 0.90, AVT 0.90, ST 0.88). Third-party statistical estimates; not primary.

4. Peer context — public peer filings and competitor data

• Public filings and market data for distribution-sector peers used for comps: TD SYNNEX (SNX), CDW, WESCO (WCC), Applied Industrial (AIT), and Watsco (WSO).
• Avnet (AVT) — FY2025 financials via ROIC.ai (revenue $22.2B, gross margin 10.7%, operating margin 2.8%, ROIC 7.6%, diluted EPS $8.26 FY2023 → $2.75 FY2025, P/B 1.30x; exited IT distribution to Tech Data in 2016).

5. Trade press and secondary (validated against primary sources)

• BusinessWire — Microsoft “Frontier” AI-cloud distributor designation (2026-06-15); Global Experience Centers launch (2026-06-09); new $1B share-repurchase authorization (2026-05-13); Q1’26 results (2026-05-07); Q2’26 call scheduling (2026-07-23).
• Seeking Alpha — “Arrow Electronics: Why I Prefer It To Avnet Today” (2026-07-11); “Still Has Room To Climb Past Its Highs” (2026-07-09); BofA Global Technology Conference presentation (2026-06-02); Q1’26 transcript (2026-05-07).
• Zacks / GuruFocus / Motley Fool / Reuters — value- and momentum-screen coverage, 52-week-high notes, AVT-vs-ARW comparisons, “AI stock up 104% YTD” (Motley Fool, 2026-06-14). Used for the news/sentiment triage layer only; material claims traced to primary filings/releases.